Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
1ABC Therapy for Diabetic Foot Ulcer
NCT03865394Phase 2Completed
- Sponsor
- Medical University of Warsaw
- Start
- Jul 2019
- Primary completion
- Mar 2021
- Modality
- Hydrogel Systems, Stem Cell Therapies
- Countries
- 1
01
Overview
Phase 2 trial of allogeneic adipose-derived mesenchymal stem cells + fibrin gel in diabetic foot ulcer (DFU) (2 arms), sponsored by Medical University of Warsaw. Primary endpoint: Changes in wound size at 8 weeks. Started Jul 2019; status: completed.
02
Drugs
allogeneic adipose-derived mesenchymal stem cells + fibrin gel
03
Conditions
diabetic foot ulcer (DFU)
Beyond the preview
Go deeper on NCT03865394.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03865394.